Supermarket pharmacists greeted the news that the Food and Drug Administration had approved low-dose naproxen sodium as a general-purpose analgesic with enthusiasm. Most think this latest switch from prescription to over-the-counter status will be a big seller. The new OTC analgesic, named Aleve, contains 200-milligram naproxen and 20-milligram sodium. It was approved by FDA Jan. 11, and is being manufactured by Syntex, Palo Alto, Calif., and marketed by Procter & Gamble, Cincinnati. ...
REGISTER TO VIEW THIS ARTICLE - Register for a Free Account
Why Register for FREE?
Registering for content on Supermarket News will give you INSTANT access to invaluable articles and media content that industry professionals rely on. You will have access to our special reports, feature articles, and industry analysis. It’s FREE, easy and quick. What are you waiting for! In addition you will also receive complimentary access to the SN salary survey data tables.
Attention Paid Print Subscribers: While you have already been granted free access to SN we ask that you register now. We promise it will only take a few minutes! Or visit your profile and add your print magazine account number and zip code.